Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
4.500
+0.090 (2.04%)
At close: Feb 6, 2026, 4:00 PM EST
4.480
-0.020 (-0.44%)
After-hours: Feb 6, 2026, 6:20 PM EST
Evolus Market Cap
Evolus has a market cap or net worth of $291.69 million as of February 6, 2026. Its market cap has decreased by -67.14% in one year.
Market Cap
291.69M
Enterprise Value
403.06M
1-Year Change
-67.14%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $291.69M, an increase of 7.52%. That is a compound annual growth rate of 0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 291.70M | -32.34% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 479.80M |
| Organogenesis Holdings | 478.46M |
| Kamada | 468.30M |
| Canopy Growth | 418.19M |
| Eton Pharmaceuticals | 395.83M |
| Akebia Therapeutics | 368.86M |
| Lifecore Biomedical | 283.62M |
| Journey Medical | 277.69M |